华氏巨球蛋白血症患者的新型冠状病毒2型感染：一项多中心国际队列研究 - Suppr

SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study.

作者信息

Defrancesco Irene, Ferretti Virginia Valeria, Morel Pierre, Kyriakou Charalampia, Kastritis Efstathios, Tohidi-Esfahani Ibrahim, Tedeschi Alessandra, Buske Christian, García-Sanz Ramón, Vos Josephine M I, Peri Veronica, Margiotta Casaluci Gloria, Ferrari Angela, Piazza Francesco, Oostvogels Rimke, Lovato Ester, Montes Lydia, Fornecker Luc Matthieu, Grunenberg Alexander, Dimopoulos Meletios Athanasios, Tam Constantine S, D'Sa Shirley, Leblond Veronique, Trotman Judith, Passamonti Francesco, Arcaini Luca, Varettoni Marzia

机构信息

Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy.

出版信息

Hemasphere. 2023 Jun 2;7(6):e887. doi: 10.1097/HS9.0000000000000887. eCollection 2023 Jun.

DOI:10.1097/HS9.0000000000000887

PMID:37283569

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10241499/

Abstract

摘要

相似文献

SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study.华氏巨球蛋白血症患者的新型冠状病毒2型感染：一项多中心国际队列研究

Hemasphere. 2023 Jun 2;7(6):e887. doi: 10.1097/HS9.0000000000000887. eCollection 2023 Jun.

IgA and IgG hypogammaglobulinemia in Waldenström's macroglobulinemia.华氏巨球蛋白血症中的 IgA 和 IgG 低丙种球蛋白血症。

Haematologica. 2010 Mar;95(3):470-5. doi: 10.3324/haematol.2009.010348. Epub 2009 Nov 10.

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.瓦尔登斯特伦巨球蛋白血症中的 MYD88 L265P 体细胞突变。

N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.

A false positive serology test of SARS‑CoV‑2 in a patient with Waldenström's macroglobulinemia: A case report.华氏巨球蛋白血症患者出现严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清学假阳性检测结果：一例报告

Exp Ther Med. 2023 Mar 21;25(5):200. doi: 10.3892/etm.2023.11899. eCollection 2023 May.

L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.MYD88 基因的 L265P 突变在华氏巨球蛋白血症中很常见，而在骨髓瘤中则不存在。

PLoS One. 2013 Nov 5;8(11):e80088. doi: 10.1371/journal.pone.0080088. eCollection 2013.

Novel agents in the treatment of Waldenström's macroglobulinemia.治疗华氏巨球蛋白血症的新型药物

Clin Lymphoma Myeloma. 2007 Aug;7 Suppl 5:S199-206. doi: 10.3816/clm.2007.s.023.

Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.idelalisib治疗1例难治性华氏巨球蛋白血症合并无尿性肾衰竭患者：病例报告

J Med Case Rep. 2018 Jun 12;12(1):164. doi: 10.1186/s13256-018-1694-z.

Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.意义未明的单克隆丙种球蛋白病和华氏巨球蛋白血症。

Best Pract Res Clin Haematol. 2016 Jun;29(2):187-193. doi: 10.1016/j.beha.2016.08.015. Epub 2016 Sep 4.

Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.支持诊断和决定治疗骨髓外华氏巨球蛋白血症的胸腔液 MYD88 L265P 突变：一例报告。

J Med Case Rep. 2020 Jul 13;14(1):98. doi: 10.1186/s13256-020-02404-x.

Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.双侧持续性浆液性黄斑脱离伴华氏巨球蛋白血症。

Optom Vis Sci. 2005 Jul;82(7):573-8. doi: 10.1097/01.opx.0000171333.64652.a4.

本文引用的文献

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.新型冠状病毒（SARS-CoV-2）感染慢性淋巴细胞白血病患者：意大利血液病学联盟 COVID-19 队列研究。

Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.接种疫苗的血液系统恶性肿瘤患者突破性 COVID-19：来自 EPICOVIDEHA 调查的结果。

Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257.

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.COVID-19 严重程度和死亡率在 CLL 患者中的研究：国际 ERIC 和 Campus CLL 研究的更新。

Leukemia. 2021 Dec;35(12):3444-3454. doi: 10.1038/s41375-021-01450-8. Epub 2021 Nov 1.

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).COVID-19 感染成年血液病患者：欧洲血液学协会调查（EPICOVIDEHA）。

J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0.

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.淋巴瘤合并 COVID-19 患者的预后模型：一项多中心队列研究。

Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.接受B细胞耗竭免疫疗法治疗的非霍奇金淋巴瘤患者感染新冠病毒后住院时间延长且死亡率更高。

Am J Hematol. 2021 Aug 1;96(8):934-944. doi: 10.1002/ajh.26209. Epub 2021 May 12.

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study.淋巴瘤患者感染新型冠状病毒肺炎的危险因素及死亡率：一项多中心研究

Hemasphere. 2021 Feb 10;5(3):e538. doi: 10.1097/HS9.0000000000000538. eCollection 2021 Mar.

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.血液系统恶性肿瘤合并 COVID-19 患者的结局：对 3377 例患者的系统评价和荟萃分析。

Blood. 2020 Dec 17;136(25):2881-2892. doi: 10.1182/blood.2020008824.

Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study.新冠病毒肺炎合并淋巴瘤住院患者的预后决定因素：一项回顾性多中心队列研究。

EClinicalMedicine. 2020 Oct;27:100549. doi: 10.1016/j.eclinm.2020.100549. Epub 2020 Oct 13.

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic.关于COVID-19大流行期间华氏巨球蛋白血症患者管理的共识声明。

Hemasphere. 2020 Jul 30;4(4):e433. doi: 10.1097/HS9.0000000000000433. eCollection 2020 Aug.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献